NeuBase Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€737.63K - Gross profit
-€737.03K - SG&A expenses
€7.87M - R&D expenses
€3.70M - EBITDA
-€11.14M - D&A
€1.78M - EBIT
-€13.17M - Interest expenses
€4.38K - EBT
-€11.85M - Tax expenses
-€837.46K - Net income
-€11.85M
Cash flow statement
- Net deferred tax
€48.70K - Non-cash items
€865.63 - Changes in working capital
-€1.76M - Operating cash flow
-€12.76M - Capex
€54.63K - Other investing cash flow
€7.34 - Net investing cash flow
-€47.29K - Total cash dividends paid
€0.00 - Issuance of common stock
€3.84M - Debt repayment
€0.00 - Other financing cash flow
€3.67M - Net financing cash flow
€3.67M - Foreign exchange effects
€2.14 - Net change in cash
-€9.13M - Cash at end of period
€10.85M - Free cash flow
-€12.70M
Balance sheet
- Cash and cash equivalents
€10.85M - Cash and short-term investments
€10.85M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€80.22K - Total current assets
€11.52M - Property, plant & equipment
€4.44M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€108.22K - Total non-current assets
€4.55M - Total assets
€16.07M - Accounts payable
€223.22K - Short-term debt
€432.22K - Other current liabilities
€2.93M - Total current liabilities
€4.01M - Long-term debt
€4.17M - Deferred tax liabilities
€0.00 - Other non-current liabilities
-€0.00 - Total non-current liabilities
€4.17M - Total liabilities
€8.19M - Common stock
€321.91 - Retained earnings
-€100.52M - Other equity
€0.00 - Total equity
€7.89M - Total liabilities and shareholders' equity
€16.07M
Company information
- Market capitalization
€1.21M - Employees
37 - Enterprise Value
-€15.74M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-150.3% Much better than peer group: -10,954.2% - ROA
-
-73.7% Much better than peer group: -10,859.1% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-1,059.2% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€320.26K